Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies

British Journal of Haematology

Volumn 97, Issue 2, 1997, Pages 409-417

  Wang, Dakun ^a   Freeman, Gordon J ^a   Levine, Herbert ^a   Ritz, Jerome ^a   Robertson, Michael J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APO 1; apoptosis; CD40; CD95; Fas

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; PROTEIN BCL 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0030971074     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.422688.x     Document Type: Article

References (59)

1. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N. & Nagata, S. (1996) Enhanced and accelerated lymphoproliferation in Fas-null mice. Proceedings of the National Academy of Sciences of the United States of America, 93, 2133-2136.
2. Aiello, A., Delia, D., Borrello, M.G., Biassoni, D., Giardini, R., Fontanella, E., Pezzella, F., Pulford, K., Pierotti, M. & Porta, G.D. (1992) Flow cytometric detection of the mitochondrial bel-2 protein in normal and neoplastic human lymphoid cells. Cytometry, 13, 502-509.
3. Alderson, M.R., Armitage, R.J., Maraskovsky, E., Tough, T.W. Roux, E., Schooley, K., Ramsdell, F. & Lynch, D.H. (1993) Fas transduces activation signals in normal human T lymphocytes. Journal of Experimental Medicine, 178, 2231-2235.
4. Baker, S.J. & Reddy, E.P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene, 12, 1-9.
5. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F. & Saeland, S. (1994) The CD40 antigen and its ligand. Annual Review of Immunology, 12, 881-922.
6. Bishop, J.M. (1991) Molecular themes in oncogenesis. Cell, 64, 235-248.
7. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V. & Wallach, D. (1996) Involvement of MACH, a novel MORT-1/FADD-interacting protease in Fas/APO-1- and TNF-induced cell death. Cell, 85, 803-815.
8. Castigli, E., Young, F., Carossino, A.M., Alt, F.W. & Geha, R.S. (1996) CD40 expression and function in murine B cell ontogeny. International Immunology, 8, 405-411.
9. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. & Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
10. 1, function upstream of the Ced-3-like apoptotic proteases. Journal of Biological Chemistry, 271, 4573-4576.
11. Chu, K., Niu, X. & Williams, L.T. (1995) A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 92, 11894-11848.
12. Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. & Sarfati, M. (1992) Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-1 expression. Journal of Experimental Medicine, 176, 1319-1326.
13. Daniel, P.T. & Krammer, P.H. (1994) Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. Journal of Immunology, 152, 5624-5632.
14. Debatin, K.-M., Goldman, C.K., Waldmann, T.A. & Krammer, P.H. (1993) APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood, 81, 2972-2977.
15. Debatin, K.-M. & Krammer, P.H. (1995) Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program. Leukemia, 9, 815-820.
16. Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W.W., Kamen, R., Weichselbaum, R. & Kufe, D. (1995) Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO Journal, 14, 6148-5156.
17. Fluckiger, A.-C., Durand, I. & Banchereau, J. (1994) Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. Journal of Experimental Medicine, 179, 91-99.
18. Funakoshi, S., Longo, D.L., Beckwith, M., Conley, D.K., Tsarfaty, G., Tsarfaty, I., Armitage, R.J., Fanslow, W.C., Spriggs, M.K. & Murphy, W.J. (1994) Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood, 83, 2787-2794.
19. Garrone, P., Neidhardt, E.-M., Garcia, E., Galibert, L., van Kooten, C. & Banchereau, J. (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. Journal of Experimental Medicine, 182, 1265-1275.
20. Henkart, P.A. (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity, 1, 345-346.
21. Hess, S. & Engelmann, H. (1996) A novel function of CD40: induction of cell death in transformed cells. Journal of Experimental Medicine, 183, 159-167.
22. Hsu, H., Shu, H-B., Pan, M.-G. & Goeddel, D.V. (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84, 299-308.
23. Itoh, N., Tsujimoto, Y. & Nagata, S. (1993) Effect of bcl-2 on Fas antigen-mediated cell death. Journal of Immunology, 151, 621-627.
24. Kansas, G.S. & Tedder, T.F. (1991) Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. Journal of Immunology 147, 4094-4102.
25. Kondo, E., Yoshino, T., Yamadori, I., Matsuo, Y., Kawasaki, N., Minowada, J. & Akagi, T. (1994) Expression of bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. American Journal of Pathology, 145, 330-337.
26. Korsmeyer, S.J. (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
27. Mainou-Fowler, T. Craig, V.A., Copplestone, J.A., Hamon, M.D. & Prentice, A.G. (1994) Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression, and is inhibited by IL-4. Blood, 84, 2297-2504.
28. Mapara, M.Y., Bargou, R., Zugck, C., Dohner, H., Ustaoglu, F., Jonker, R.R., Krammer, P.H. & Dorken, B. (1993) APO-1 mediated apoptosis or proliferation in human chronic B cell lymphocytic leukemia: correlation with bcl-2 oncogene expression. European Journal of Immunology, 23, 702-708.
29. Moller, P., Henne, C., Leithauser, F., Eichelmann, A., Schmidt, A., Bruderlein, S., Dein, J. & Krammer, P.H. (1993) Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B cell lymphomas. Blood, 81, 2067-2075.
30. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., Mann, M., Krammer, P.H., Peter, M.E. & Dixit, V.M. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell, 85, 817-827.
31. Nagata, S. & Golstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
32. Nguyen, P.L., Harris, N.L., Ritz, J. & Robertson, M.J. (1996) Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. American Journal of Pathology, 148, 847-853.
33. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. & Riccardi, C. (1991) A simple and rapid method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods, 139, 271-279.
34. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. & Nagata, S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature, 364, 806-809.
35. Panayiotidis, P., Ganeshaguru, K., Foroni, L. & Hoffbrand, A.V. (1995) Expression and function of the Fas antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia, 9, 1227-1232.
36. Ranheim, E.A. & Kipps, T.J. (1993) Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. Journal of Experimental Medicine, 177, 925-935.
37. Reed, J.C. (1994) Bcl-2 and the regulation of programmed cell death. Journal of Cell Biology, 124, 1-6.
38. Rensing-Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S.M., Weller, M., Aebischer, P., Krammer, P.H. & Fontana, A. (1995) Local Fas/ APO-1 (CD95) ligand-mediated tumor cell killing in vivo. European Journal of Immunology, 25, 2253-2258.
39. Robertson, M.J., Manley, T.J., Pichert, G., Cameron, C., Cochran, K.J., Levine, H. & Ritz, J. (1995a) Functional consequences of APO-1/ Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leukemia and Lymphoma, 17, 51-61.
40. Robertson, M.J., Manley, T.J., Pichert, G. & Ritz, J. (1995b) Expression and function of APO-1/Fas (CD95) antigen on normal human lymphocytes. Leucocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al), Vol. 2, pp. 1423-1425, Oxford University Press.
41. Robertson, M.J. & Ritz, J. (1995) Cluster report: CD95, Leucocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al), Vol. 1. pp. 1142-1143, Oxford University Press.
42. Robertson, M.J., Soiffer, R.J., Wolf, S.F., Manley, T.J., Donahue, C., Young, D., Herrmann, S.H. & Ritz, J. (1992) Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells is differentially regulated by NKSF. Journal of Experimental Medicine, 175, 779-788.
43. Saeland, S., Duvert, V., Moreau, I. & Banchereau, J. (1993) Human B cell precursors proliferate and express CD23 after CD40 ligation. Journal of Experimental Medicine, 178, 113-120.
44. Sato, T., Irie, S., Kitada, S. & Reed, J.C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science, 268, 411-415.
45. Schattner, E.J., Elkon, K.B., Yoo, D.-H., Tumang, J., Krammer, P.H., Crow, M.K. & Friedman, S.M. (1995) CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. Journal of Experimental Medicine, 182, 1557-1565.
46. Schultze, J.L., Cardoso, A.A., Freeman, G.J., Seamon, M.J., Daley, J., Pinkus, G.S., Gribben, J.G. & Nadler, L.M. (1995) Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proceedings of the National Academy of Sciences of the United States of America, 92, 8200-8204.
47. Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Yoshizaki, K. & Kishimoto, T. (1995) Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood, 85, 757-764.
48. Stanger, B.Z., Leder, P., Lee, T.-H., Kim, E. & Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
49. Strasser, A., Harris, A.W., Huang, D.C.S., Krammer, P.H. & Cory, S. (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO Journal, 14, 6136-6147.
50. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T. & Nagata, S. (1994) Generalized lymphoproliferative disorder in mice, caused by a point mutation in the Fas ligand. Cell, 76, 969-976.
51. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J.A. & Reed, J.C. (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-284.
52. Tamura, A., Katsumata, M., Greene, M.I. & Yui, K. (1996) Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-deficient mice. Cellular Immunology, 168, 220-228.
53. Thompson, C.B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
54. Trauth, B.C., Klas, C., Peters, A.M.J., Matzku, S., Moller, P., Falk, W., Debatin, K.-M. & Krammer, P.H. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305.
55. Uckun, F.M., Gajl-Peczalska, K., Myers, D.E., Jaszcz, W., Haissig, S. & Ledbetter, J.A. (1990) Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood, 76, 2449-2456.
56. Uckun, F.M., Schieven, G.L., Dibirdik, I., Chandan-Langlie, M., Tuel-Ahlgren, L. & Ledbetter, J.A. (1991) Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. Journal of Biological Chemistry, 266, 17478-17485.
57. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. (1992) Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356, 314-317.
58. Westendorf, J.J., Lammert, J.M. & Jelinek, D.F. (1995) Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood, 85, 3566-3576.
59. Yellin, M.J., Sinning, J., Covey, L.R., Sherman, W., Lee, J.J., Glickman-Nir, E., Sippel, K.C., Rogers, J., Cleary, A.M., Parker, M., Chess, L. & Lederman, S. (1994) T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. Journal of Immunology, 153, 666-674.